- Report
- March 2024
- 191 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- November 2023
- 178 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- July 2023
- 180 Pages
Global
From €5730EUR$5,950USD£4,928GBP
- Report
- January 2020
- 40 Pages
Saudi Arabia
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
India
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
United States
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Russia
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Japan
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Ireland
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Germany
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
France
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
China
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Brazil
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 80 Pages
Africa
From €3655EUR$3,795USD£3,143GBP
The Allergy Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent or reduce the severity of infectious diseases. Allergy Vaccines are specifically designed to reduce the severity of allergic reactions, such as hay fever, asthma, and food allergies. These vaccines are typically administered through a series of injections, which can be tailored to the individual patient's needs.
Allergy Vaccines are becoming increasingly popular as a way to reduce the burden of allergic reactions, and are being used in both adults and children. They are also being used in combination with other treatments, such as antihistamines and immunotherapy, to provide a more comprehensive approach to managing allergies.
Some companies in the Allergy Vaccine market include ALK-Abello, Stallergenes Greer, Allergy Therapeutics, and DBV Technologies. Show Less Read more